Loss of hexokinase 1 sensitizes ovarian cancer to high-dose metforminDaniela Šimčíková(Charles University), Petr Heneberg(Charles University)Cancer & MetabolismDecember 1, 202110.1186/s40170-021-00277-2Cited by 9SaveCiteExport RISWatch citationsRelated PapersMetabolism of primary high-grade serous ovarian carcinoma (HGSOC) cells under limited glutamine or glucose availability|Cancer & Metabolism|2024|5